HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
$3.74
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$3.74
Sarado: Dis 31, 4:03:05 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.77
Sakop ng araw
$3.68 - $3.80
Sakop ng taon
$1.00 - $6.60
Market cap
178.05M USD
Average na Volume
286.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 12.19M | 12.58% |
Net na kita | 45.45M | 539.11% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -11.91M | -15.19% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 110.88M | 264.73% |
Kabuuang asset | 183.45M | 241.00% |
Kabuuang sagutin | 18.37M | 8.76% |
Kabuuang equity | 165.07M | — |
Natitirang share | 47.61M | — |
Presyo para makapag-book | 1.08 | — |
Return on assets | -29.68% | — |
Return on capital | -33.42% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 45.45M | 539.11% |
Cash mula sa mga operasyon | -13.05M | -107.41% |
Cash mula sa pag-invest | -129.87M | -11,167.05% |
Cash mula sa financing | 168.69M | 25,123.21% |
Net change in cash | 25.73M | 418.82% |
Malayang cash flow | -5.10M | -62.67% |
Tungkol
Itinatag
2014
Headquarters
Website
Mga Empleyado
63
